Fiorentino Grasso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fiorentino Grasso has a total of 313 co-authors. Here are the top co-authors by number of shared publications:
Antonella Capasso
Department of Translational Medical Sciences, Neonatology and Neonatal Intensive Care Unit, University of Naples Federico II, Naples, Italy
5 shared publicationsFrancesco Raimondi
Department of Translational Medical Sciences, Neonatology and Neonatal Intensive Care Unit, University of Naples Federico II, Naples, Italy
5 shared publications- Francesco Raimondi
Division of Neonatology, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
5 shared publications Letizia Capasso
Department of Translational Medical Sciences, Neonatology and Neonatal Intensive Care Unit, University of Naples Federico II, Naples, Italy
5 shared publications- Letizia Capasso
Division of Neonatology, Department of Translational Medical Sciences Università Federico II di Napoli Naples Italy
3 shared publications - Adele Primavera
Ospedale "Ss Annunziata", Chieti - Università Degli Studi G. D'Annunzio Chieti, Pescara, Italy
2 shared publications
Latest Publications
- 15 September 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (10) , 751
Feasibility and procedural outcomes of ultrasound-guided brachiocephalic vein cannulation in neonates weighing less than 1,000 g: a prospective study
Purpose To evaluate the anatomical feasibility and procedural outcomes of ultrasound-guided right brachiocephalic vein cannulation for placing non-tunnelled centrally inserted central catheters in neonates weighing less than 1,000 g. Methods This single-center, prospective observational study assessed right BCV diameter using high-frequency ultrasound (Phase 1), defining anatomical feasibility as a diameter ≥ 2.0 mm (suitable for a 2 French catheter). Subsequently, ultrasound-guided cannulation was evaluated using a standardized "micro-access" bundle (Phase 2), measuring technical success, first-pass rate, and immediate complications. Results Sixty neonates were enrolled (median weight, 865 g [interquartile interval, 620 to 970 g]). Anatomical feasibility was 100% (60/60); median diameter was 2.8 mm (interquartile interval, 2.6 to 3.0 mm). Right brachiocephalic vein diameter was significantly smaller in neonates weighing less than 750 g (n = 22) than in those weighing 750 to 1,000 g (n = 38) (median, 2.6 mm [interquartile interval, 2.4 to 2.7 mm] versus 2.95 mm [interquartile interval, 2.8 to 3.1 mm]; p < 0.001). Fifty-two catheterization procedures were performed in 47 infants. Technical success was 100% (52/52), with a first-pass success rate of 76.9% (40/52). No statistically significant difference in first-pass success was detected between the two weight groups (77.3% [17/22] in < 750 g versus 76.7% [23/30] in ≥ 750 g; p = 1.00). No immediate complications were observed (0/52). Conclusion Ultrasound-guided right brachiocephalic vein cannulation is anatomically feasible and safe in neonates weighing less than 1,000 g, providing a reproducible central venous access pathway when performed with a standardized micro-access protocol. What is Known: • Centrally inserted central catheters offer superior performance compared to peripherally inserted central catheters in infants, although clinical data regarding their placement in micro-preterm neonates remain limited. What is New: • The right brachiocephalic vein caliber consistently exceeds 2.0 mm in neonates weighing < 1,000 g, and a standardized "micro-access" bundle yields high technical success without immediate mechanical complications.
- 15 September 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (10) , 751
Feasibility and procedural outcomes of ultrasound-guided brachiocephalic vein cannulation in neonates weighing less than 1,000 g: a prospective study
Purpose To evaluate the anatomical feasibility and procedural outcomes of ultrasound-guided right brachiocephalic vein cannulation for placing non-tunnelled centrally inserted central catheters in neonates weighing less than 1,000 g. Methods This single-center, prospective observational study assessed right BCV diameter using high-frequency ultrasound (Phase 1), defining anatomical feasibility as a diameter ≥ 2.0 mm (suitable for a 2 French catheter). Subsequently, ultrasound-guided cannulation was evaluated using a standardized "micro-access" bundle (Phase 2), measuring technical success, first-pass rate, and immediate complications. Results Sixty neonates were enrolled (median weight, 865 g [interquartile interval, 620 to 970 g]). Anatomical feasibility was 100% (60/60); median diameter was 2.8 mm (interquartile interval, 2.6 to 3.0 mm). Right brachiocephalic vein diameter was significantly smaller in neonates weighing less than 750 g (n = 22) than in those weighing 750 to 1,000 g (n = 38) (median, 2.6 mm [interquartile interval, 2.4 to 2.7 mm] versus 2.95 mm [interquartile interval, 2.8 to 3.1 mm]; p < 0.001). Fifty-two catheterization procedures were performed in 47 infants. Technical success was 100% (52/52), with a first-pass success rate of 76.9% (40/52). No statistically significant difference in first-pass success was detected between the two weight groups (77.3% [17/22] in < 750 g versus 76.7% [23/30] in ≥ 750 g; p = 1.00). No immediate complications were observed (0/52). Conclusion Ultrasound-guided right brachiocephalic vein cannulation is anatomically feasible and safe in neonates weighing less than 1,000 g, providing a reproducible central venous access pathway when performed with a standardized micro-access protocol. What is Known: • Centrally inserted central catheters offer superior performance compared to peripherally inserted central catheters in infants, although clinical data regarding their placement in micro-preterm neonates remain limited. What is New: • The right brachiocephalic vein caliber consistently exceeds 2.0 mm in neonates weighing < 1,000 g, and a standardized "micro-access" bundle yields high technical success without immediate mechanical complications.
- 14 July 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (7) , e71739
Electrical Impedance Tomography and Lung Ultrasound, a New Combined Non‐Invasive Approach for Neonatal Respiratory Distress: A Case Report
- 14 July 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (7) , e71739
Electrical Impedance Tomography and Lung Ultrasound, a New Combined Non‐Invasive Approach for Neonatal Respiratory Distress: A Case Report
- 23 May 2026
- Published by S. Karger AG in Neonatology
- p. 1-15
Ultrasound-Guided Non-Tunneled Centrally Inserted Central Catheters versus Peripherally Inserted Central Catheters in Neonates Under 1000 grams: A Comparative Cohort Study
Introduction: Peripherally inserted central catheters (n-PICCs) are standard in neonatal intensive care but carry high complication rates. Ultrasound-guided non-tunneled centrally inserted central catheters (nT-CICCs) offer a potential alternative. This study compared outcomes of nT-CICCs versus n-PICCs in extremely low birth weight (ELBW) neonates. Methods: Single-center, comparative cohort study (April 2022–October 2025) enrolling neonates <1000g requiring central venous access. A retrospective cohort receiving n-PICCs was compared with a prospective cohort receiving nT-CICCs. The primary outcome was Central Line-Associated Bloodstream Infection (CLABSI) density rate on successfully placed catheters. Secondary outcomes included procedural success, mechanical complications, and risk factors for CLABSI. Results: We analyzed 103 catheter insertions (50 nT-CICCs, 53 n-PICCs). Procedural success was 100% for nT-CICCs and 94% for n-PICCs (3 immediate failures excluded from follow-up). Among 100 indwelling catheters, nT-CICCs showed significantly lower CLABSI rates (1.83 vs 11.09 per 1000 catheter-days; P = .038). Overall complications affected 4% of the nT-CICC group versus 64% of the n-PICC group (P < .001). nT-CICCs enabled therapy completion in 66% of cases compared with 12% for n-PICCs. Catheter type was the sole independent predictor of CLABSI (adjusted HR 7.1, 95% CI 1.01-49.74; P = .048). Conclusions: Ultrasound-guided nT-CICCs are associated with significantly lower rates of infectious and mechanical complications compared with n-PICCs in ELBW neonates. This approach provides a safer and more durable option for central venous access in this vulnerable population.
- 23 May 2026
- Published by S. Karger AG in Neonatology
- p. 1-15
Ultrasound-Guided Non-Tunneled Centrally Inserted Central Catheters versus Peripherally Inserted Central Catheters in Neonates Under 1000 grams: A Comparative Cohort Study
Introduction: Peripherally inserted central catheters (n-PICCs) are standard in neonatal intensive care but carry high complication rates. Ultrasound-guided non-tunneled centrally inserted central catheters (nT-CICCs) offer a potential alternative. This study compared outcomes of nT-CICCs versus n-PICCs in extremely low birth weight (ELBW) neonates. Methods: Single-center, comparative cohort study (April 2022–October 2025) enrolling neonates <1000g requiring central venous access. A retrospective cohort receiving n-PICCs was compared with a prospective cohort receiving nT-CICCs. The primary outcome was Central Line-Associated Bloodstream Infection (CLABSI) density rate on successfully placed catheters. Secondary outcomes included procedural success, mechanical complications, and risk factors for CLABSI. Results: We analyzed 103 catheter insertions (50 nT-CICCs, 53 n-PICCs). Procedural success was 100% for nT-CICCs and 94% for n-PICCs (3 immediate failures excluded from follow-up). Among 100 indwelling catheters, nT-CICCs showed significantly lower CLABSI rates (1.83 vs 11.09 per 1000 catheter-days; P = .038). Overall complications affected 4% of the nT-CICC group versus 64% of the n-PICC group (P < .001). nT-CICCs enabled therapy completion in 66% of cases compared with 12% for n-PICCs. Catheter type was the sole independent predictor of CLABSI (adjusted HR 7.1, 95% CI 1.01-49.74; P = .048). Conclusions: Ultrasound-guided nT-CICCs are associated with significantly lower rates of infectious and mechanical complications compared with n-PICCs in ELBW neonates. This approach provides a safer and more durable option for central venous access in this vulnerable population.
- Open Access
- 20 December 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1)
Ultrasound-guided tip location and detection of tip migration of neonatal peripherally inserted central catheters: a prospective, multicenter study (DISLOTIP study)
Incorrect neonatal peripherally inserted central catheter (n-PICC) tip positioning and secondary migration lead to serious complications. Identifying an ac
- 20 December 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1)
Open AccessUltrasound-guided tip location and detection of tip migration of neonatal peripherally inserted central catheters: a prospective, multicenter study (DISLOTIP study)
Incorrect neonatal peripherally inserted central catheter (n-PICC) tip positioning and secondary migration lead to serious complications. Identifying an ac
- 1 July 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (7) , 460
Are lung ultrasound and chest radiograph equally reliable for neonatal imaging? A scoping review
Chest radiograph (CR) has traditionally been the standard in imaging neonatal respiratory diseases. Lung ultrasound (LUS) has recently emerged as a radiation-free alternative. This scoping review compares the reliability of these two techniques for diagnosing respiratory distress syndrome (RDS), evaluating the need of surfactant replacement, and predicting the development of bronchopulmonary dysplasia (BPD). A literature search was conducted in PubMed, Embase, and Cochrane Library for studies published between 1974 and December 2024. The following search terms were used: "neonate," "lung ultrasound," "chest radiography," "reliability," "Respiratory Distress Syndrome," "Bronchopulmonary Dysplasia," and "surfactant administration." The search was limited to full articles. Only studies evaluating the inter- and intra-observer agreement were included. Out of 322 evaluated papers, 14 met the inclusion criteria and were included in this review. LUS had four papers (308 neonates) for RDS diagnosis with Cohen's k or intraclass correlation coefficient (ICC) ≥ 0.9, four studies (480 neonates) for the need of surfactant replacement with Cohen's k ≥ 0.83, and three papers for BPD prediction (280 infants) showing a Cohen's k ≥ 0.82. We found no publication on CR reliability for RDS diagnosis, one paper on 56 neonates on its prediction of surfactant need with a Cohen's k = 0.86, and two studies (146 neonates) on BPD prediction with Cohen's k ranging from 0.19 to 0.41. We show that, unlike CR, LUS has good quality evidence in favor of its reliability for both diagnosis and prognosis of significant neonatal respiratory diseases and guiding surfactant delivery. • CR has traditionally been the standard imaging method for neonatal respiratory diseases. • LUS has emerged as a radiation-free and highly accurate alternative. • This review indicates that LUS offers robust evidence of its high reliability for the diagnosis and prognosis of neonatal respiratory distress syndrome, and for guiding surfactant delivery. In stark contrast, there is a concerning absence of solid evidence regarding CR's reliability for the aforementioned conditions.
- 1 July 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (7) , 460
Are lung ultrasound and chest radiograph equally reliable for neonatal imaging? A scoping review
Chest radiograph (CR) has traditionally been the standard in imaging neonatal respiratory diseases. Lung ultrasound (LUS) has recently emerged as a radiation-free alternative. This scoping review compares the reliability of these two techniques for diagnosing respiratory distress syndrome (RDS), evaluating the need of surfactant replacement, and predicting the development of bronchopulmonary dysplasia (BPD). A literature search was conducted in PubMed, Embase, and Cochrane Library for studies published between 1974 and December 2024. The following search terms were used: "neonate," "lung ultrasound," "chest radiography," "reliability," "Respiratory Distress Syndrome," "Bronchopulmonary Dysplasia," and "surfactant administration." The search was limited to full articles. Only studies evaluating the inter- and intra-observer agreement were included. Out of 322 evaluated papers, 14 met the inclusion criteria and were included in this review. LUS had four papers (308 neonates) for RDS diagnosis with Cohen's k or intraclass correlation coefficient (ICC) ≥ 0.9, four studies (480 neonates) for the need of surfactant replacement with Cohen's k ≥ 0.83, and three papers for BPD prediction (280 infants) showing a Cohen's k ≥ 0.82. We found no publication on CR reliability for RDS diagnosis, one paper on 56 neonates on its prediction of surfactant need with a Cohen's k = 0.86, and two studies (146 neonates) on BPD prediction with Cohen's k ranging from 0.19 to 0.41. We show that, unlike CR, LUS has good quality evidence in favor of its reliability for both diagnosis and prognosis of significant neonatal respiratory diseases and guiding surfactant delivery. • CR has traditionally been the standard imaging method for neonatal respiratory diseases. • LUS has emerged as a radiation-free and highly accurate alternative. • This review indicates that LUS offers robust evidence of its high reliability for the diagnosis and prognosis of neonatal respiratory distress syndrome, and for guiding surfactant delivery. In stark contrast, there is a concerning absence of solid evidence regarding CR's reliability for the aforementioned conditions.
- 28 October 2024
- Published by Springer Nature in European Radiology
- Vol. 35 (1) , 309-310
Radiation exposure and estimated cancer risk in neonates: a cautionary perspective
- 28 October 2024
- Published by Springer Nature in European Radiology
- Vol. 35 (1) , 309-310
Radiation exposure and estimated cancer risk in neonates: a cautionary perspective
- Open Access
- 2 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 433
Comparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial)
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD); however, the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less-invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study, 382 infants born at 24+0–27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. The secondary outcomes are BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular hemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes; and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include center and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0–27+6 weeks’ gestation affected by RDS and failing nCPAP or NIPPV during the first 24 h of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks’ postmenstrual age of life. Trial registration: ClinicalTrials.gov NCT05711966. Registered on February 3, 2023.
- 2 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 433
Open AccessComparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial)
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD); however, the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less-invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study, 382 infants born at 24+0–27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. The secondary outcomes are BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular hemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes; and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include center and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0–27+6 weeks’ gestation affected by RDS and failing nCPAP or NIPPV during the first 24 h of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks’ postmenstrual age of life. Trial registration: ClinicalTrials.gov NCT05711966. Registered on February 3, 2023.
- Open Access
- 24 April 2024
- Published by Springer Nature in Research Square
Comparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN- REC-LISA trial)
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). Goals of different methods of surfactant administration are to reduce duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD), however the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study 382 infants born at 24+0-27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. Secondary outcomes are: BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular haemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include centre and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0-27+6 weeks' gestation affected by RDS and failing nCPAP or NIPPV during the first 24 hours of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks' postmenstrual age of life. Trial registration: ClinicalTrials.gov identifier NCT05711966
- 24 April 2024
- Published by Springer Nature in Research Square
Open AccessComparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN- REC-LISA trial)
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). Goals of different methods of surfactant administration are to reduce duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD), however the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study 382 infants born at 24+0-27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. Secondary outcomes are: BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular haemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include centre and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0-27+6 weeks' gestation affected by RDS and failing nCPAP or NIPPV during the first 24 hours of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks' postmenstrual age of life. Trial registration: ClinicalTrials.gov identifier NCT05711966
- 26 May 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 247, 181
Reply
- 1 May 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 244, 86-91.e2
Ultrasound Guided Catheter Tip Location in Neonates: A Prospective Cohort Study
- 1 May 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 244, 86-91.e2
Ultrasound Guided Catheter Tip Location in Neonates: A Prospective Cohort Study